Integrated Research Limited (ASX: IRI) - Share Price
- Current share price for IRI : $0.280
Integrated Research Limited (IRI), an ASX-listed company, is the global provider of user experience and performance management solutions for payment transactions and collaborative systems. Its principal activities are the design, development, implementation, and sale of software to monitor in real time the performance of business-critical computing, including Unified Communication networks and Payment networks.
IRI General Information +
| ASX Code | IRI |
| Website | N/A |
| Industry/Sector | Application Software |
| Market Cap ($M) | 50 |
| IRI Share Price | $0.280 |
| Day High | $0.285 |
| Day Low | $0.275 |
| Last Close | $0.280 |
| IRI Share Price Movement | - ( No change ) |
Prices as at 16:40, 29 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Integrated Research Limited (IRI) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| HFResult | 2¢ | 100% | 3 Sep 2025 | 21 Oct 2025 | - | - | - |
| HFResult | 2¢ | 100% | 2 Sep 2024 | 15 Oct 2024 | - | - | - |
| HFResult | 3.75¢ | 100% | 2 Sep 2020 | 15 Oct 2020 | - | - | - |
See all dividends from Integrated Research Limited (IRI) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Integrated Research Limited (IRI) price-sensitive announcements
IRI - FY26 Interim Results
Integrated Research Limited reported its FY26 interim results, showing a slight revenue de
Integrated Research Limited (IRI)
26 Feb 2026 | 8:43 AM
26 Feb 2026 | 8:43 AM
IRI - Appendix 4D & Interim Financial Report
Integrated Research Limited's interim financial report for the half-year ended 31 December
Integrated Research Limited (IRI)
26 Feb 2026 | 8:42 AM
26 Feb 2026 | 8:42 AM
IRI - Annual General Meeting - CEO's Presentation
The CEO's presentation at the 2025 Annual General Meeting of Integrated Research Limited h
Integrated Research Limited (IRI)
24 Nov 2025 | 9:20 AM
24 Nov 2025 | 9:20 AM
IRI - FY26 Half Year Results Trading Update
Integrated Research Limited (ASX: IRI), a global provider of IT observability solutions, a
Integrated Research Limited (IRI)
14 Nov 2025 | 9:10 AM
14 Nov 2025 | 9:10 AM
Integrated Research Limited (IRI) Recent ASX Announcements
IRI Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | $12.14 | $6.80 | -55.50% | 8.10 | 2.00 | 3.70% | 100.0% |
| 2024A | $27.13 | $15.20 | 925.70% | 2.70 | 0.00 | 0.00% | 100.0% |
| 2023A | $2.55 | $1.50 | 66.30% | 29.90 | 0.00 | 0.00% | 0.0% |
IRI Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| Life360 Inc (360) | $4,323M | -32.1265 | -0.0955 | 0.3640 | 23.6986 | 26.2004 | 19.2091 | 0.00% | 0.00% | 0.00% |
| Integrated Research Limited (IRI) | $51M | -0.5553 | 0.0000 | 0.0000 | 4.1481 | 0.0000 | 0.0000 | 7.14% | 0.00% | 0.00% |
| Technology One Limited (TNE) | $9,556M | 0.1582 | 0.1924 | 0.2094 | 69.9497 | 58.6616 | 48.5045 | 1.25% | 1.18% | 1.43% |
| Wisetech Global Limited (WTC) | $10,550M | 0.3104 | -0.1252 | 0.5623 | 29.5296 | 33.7563 | 21.6066 | 0.70% | 0.64% | 0.86% |
| Xero Limited (XRO) | $11,575M | 0.0000 | 0.0000 | 0.8378 | 0.0000 | 62.2991 | 33.8996 | 0.00% | 0.00% | 0.00% |
IRI Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Ian Lowe | Chief Executive Officer, Managing Director | 17 Oct 2024 |
| Mr Mark Ronald Brayan | Non-Executive Director | 22 Nov 2023 |
| Ms Kate Greenhill | Non-Executive Director | 19 Apr 2024 |
| Mr Michael Hitz | Non-Executive Director | 23 Oct 2023 |
| Mr Peter Lloyd | Non-Executive Director, Non-Executive Chairman | 15 Jul 2010 |
Integrated Research Limited (IRI) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 5 Dec 2025 | HITZ, Michael | Buy | Indirect Shares | 149,500 | $0.347 | $51,948.570 |
| 1 Dec 2025 | HITZ, Michael | Buy | Indirect Shares | 150,500 | $0.314 | $47,250.980 |
| 27 Nov 2025 | GREENHILL, Kate | Buy | Direct Shares | 90,000 | $0.312 | $28,088.400 |
See all changes in directors' interest & trades for Integrated Research Limited (IRI) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
IRI Management
| Name | Position |
|---|---|
| Christian Shaw | Chief Financial Officer |
| Leanne Ralph | Company Secretary |
IRI Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Integrated Research Limited (IRI). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 52,218,231 (28.92%) | Stephen John Killelea |
IRI Calendar of Events
| Date | Event |
|---|---|
| 25 February 2027 | Report (Interim) |
| 16 October 2026 | Report (Annual) |
| 25 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
